The introduction of biosimilars of low molecular weight heparins in Europe: a critical review and reappraisal endorsed by the Italian Society for Haemostasis and Thrombosis (SISET) and the Italian Society for Angiology and Vascular Medicine (SIAPAV)

Recently, the European Medicines Agency (EMA) authorized the introduction and marketing of Thorinane® and Inhixa®, biosimilars of the Low Molecular Weight Heparin (LMWH) enoxaparin. The authorization path is considerably different from the guidelines published by the EMA in 2009, as well as from the...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Thromb J
Main Authors: Imberti, Davide, Marietta, Marco, Polo Friz, Hernan, Cimminiello, Claudio
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5424282/
https://ncbi.nlm.nih.gov/pubmed/28490974
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12959-017-0136-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados